Mullish, Benjamin H.

Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial

Routy, B., Lenehan, J. G., Miller, W. H., Jamal, R., Messaoudene, M., Daisley, B. A., Hes, C., Al, K. F., Martinez-Gili, L., Punčochář, M., et al. (2023) · Nature Medicine

Cancer Immunotherapy and BiomarkersGut microbiota and health

Cited by 526

International consensus conference on stool banking for faecal microbiota transplantation in clinical practice

Cammarota, G., Ianiro, G., Kelly, C. R., Mullish, B. H., Allegretti, J. R., Kassam, Z., Putignani, L., Fischer, M., Keller, J. J., Costello, S. P., et al. (2019) · Gut

Clostridium difficile and Clostridium perfringens researchGut microbiota and health

Cited by 506

The evolution of the use of faecal microbiota transplantation and emerging therapeutic indications.

Allegretti, J. R., Mullish, B. H., Kelly, C., & Fischer, M. (2019) · The Lancet

Gut microbiota and healthClostridium difficile and Clostridium perfringens research

Cited by 358

Microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the treatment of recurrent Clostridioides difficile infection

Mullish, B. H., McDonald, J. A. K., Pechlivanis, A., Allegretti, J. R., Kao, D., Barker, G. F., Kapila, D., Petrof, E. O., Joyce, S. A., Gahan, C. G. M., et al. (2019) · Gut

Clostridium difficile and Clostridium perfringens researchGut microbiota and health

Cited by 268

Fecal microbiota transplantation in patients with primary sclerosing cholangitis: a pilot clinical trial

Allegretti, J. R., Kassam, Z., Carrellas, M., Mullish, B. H., Marchesi, J. R., Pechlivanis, A., Smith, M., Gerardin, Y., Timberlake, S., Pratt, D. S., et al. (2019) · American Journal of Gastroenterology

Liver Diseases and ImmunityGut microbiota and health

Cited by 234

Reorganisation of Faecal Microbiota Transplant Services During the COVID-19 Pandemic

Ianiro, G., Mullish, B. H., Kelly, C. R., Kassam, Z., Kuijper, E. J., Ng, S. C., Iqbal, T. H., Allegretti, J. R., Bibbò, S., Sokol, H., et al. (2020) · Gut

Clostridium difficile and Clostridium perfringens researchGut microbiota and health

Cited by 147

Review article: depression and the use of antidepressants in patients with chronic liver disease or liver transplantation

Mullish, B. H., Kabir, M. S., Thursz, M. R., & Dhar, A. (2014) · Alimentary Pharmacology & Therapeutics

Treatment of Major DepressionLiver Disease and Transplantation

Cited by 144

High-Throughput, Machine Learning-Based Quantification of Steatosis, Inflammation, Ballooning, and Fibrosis in Biopsies from Patients with Nonalcoholic Fatty Liver Disease

Forlano, R., Mullish, B. H., Giannakeas, N., Maurice, J. B., Angkathunyakul, N., Lloyd, J., Tzallas, A. T., Tsipouras, M., Yee, M., Thursz, M. R., et al. (2020) · Clinical Gastroenterology and Hepatology

Liver Disease Diagnosis and TreatmentAI in cancer detection

Cited by 142

Antibiotic therapy and outcome from immune-checkpoint inhibitors

Pinato, D. J., Gramenitskaya, D., Altmann, D. M., Boyton, R. J., Mullish, B. H., Marchesi, J. R., & Bower, M. (2019) · Journal for ImmunoTherapy of Cancer

Cancer Immunotherapy and BiomarkersGut microbiota and health

Cited by 116

Antibiotics promote intestinal growth of carbapenem-resistant Enterobacteriaceae by enriching nutrients and depleting microbial metabolites

Yip, A. Y. G., King, O. G., Omelchenko, O., Kurkimat, S., Horrocks, V., Mostyn, P., Danckert, N., Ghani, R., Satta, G., Jauneikaite, E., et al. (2023) · Nature Communications

Gut microbiota and healthAntibiotic Resistance in Bacteria

Cited by 91

A Double‐Blind, Randomized, Placebo‐Controlled Trial of Ursodeoxycholic Acid (UDCA) in Parkinson's Disease

Payne, T., Appleby, M., Buckley, E., van Gelder, L. M. A., Mullish, B. H., Sassani, M., Dunning, M. J., Hernandez, D., Scholz, S. W., McNeill, A., et al. (2023) · Movement Disorders

Parkinson's Disease Mechanisms and TreatmentsNuclear Receptors and Signaling

Cited by 76